Product Details
| Product Name:
NV03 |
CAS No.:
2448341-58-8 |
| Purity:
99.88% |
Supply Ability:
10g |
| Release date:
2026/07/16 |
Product Introduction
Bioactivity
| Name | NV03 |
| Description | NV03 is a selective antagonist of the UHRF1-H3K9me3 interaction (Kd=2.4 μM), binding to the UHRF1 tandem Tudor domain (TTD) to form a complex. It is suitable for cancer research. NV03 also functions as a ligand for E3 ligases in PROTAC synthesis. |
| Storage | Keep away from moisture,Keep away from direct sunlight,
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | NV03 | NV 03 |
| Inhibitors Related | MAK-683 hydrochloride | Lenalidomide-Br | Piribedil | PT-179 | EPZ015666 | Thalidomide | EN219 | Pomalidomide | Lenalidomide | Indole-3-carbinol | (S,R,S)-AHPC hydrochloride | MRTX-1719 |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
-
-
CAS:1103920-19-9
$1520.00
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$1360.00
|
VIP5Y
|
TargetMol Chemicals Inc.
|
2026-07-16 |
|
|
$2150.00
|
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-09-03 |
United States